Observe real-life allocation of atypical antipsychotics in the acute inpatient management of schizophrenia - RECONNECT-S
Study identifier:NIS-NME-XXX-2011/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A non- interventional study to observe real life usage of atypical antipsychotics in the acute inpatient management of schizophrenia.
Medical condition
schizophrenia
Phase
N/A
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
1050
Study type
Observational
Age
18 Years +
Date
Study Start Date: 01 Apr 2012
Estimated Primary Completion Date: 01 Dec 2012
Estimated Study Completion Date: 01 Dec 2012
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Dec 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Subjects who are hospitalized due to acute psychotic episode. All subjects who are hospitalized due to acute psychotic episode. The subjects should be managed according to normal clinical practice until discharge time. | - |
Contacts
Investigators
Principal Investigator
Talaat Matar
Obaid Alla Hospital,Ras Al Khaima,UAE
